Results 101 to 110 of about 5,593 (170)

Impact of Metabolic Health and Its Changes on Erosive Esophagitis Remission: A Cohort Study. [PDF]

J Neurogastroenterol Motil
Kim NH, Chang Y, Ryu S, Sohn CI.
europepmc   +1 more source

Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study. [PDF]

BMC Gastroenterol, 2023
Lim H, Park JK, Chung H, Lee SH, Park JM, Park JH, Kim GH, Shin SK, Hong SJ, Lee KJ, Park MI, Jung HK, Kim HS, Sung JK, Jeon SW, Choi SC, Moon JS, Kim N, Park JJ, Hong SH, Kim NY, Jung HY.   +21 more
europepmc   +1 more source

Comparative Efficacy and Safety of Tegoprazan Versus Proton Pump Inhibitors for Erosive Esophagitis: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Hussaini H, Kebede TM, Afework TS, Kumari D, Fadeyi O, Chaudhari SS, Habib I, Hirani S.   +7 more
europepmc   +1 more source

Association between sitting-time at work and incidence of erosive esophagitis diagnosed by esophagogastroduodenoscopy: a Korean cohort study. [PDF]

Ann Occup Environ Med, 2022
Kim D, Lee Y, Mun E, Seo E, Lee J, Jeong Y, Jeong J, Lee W.   +7 more
europepmc   +1 more source

A Randomized, Comparative Trial of a Potassium-Competitive Acid Blocker (X842) and Lansoprazole for the Treatment of Patients With Erosive Esophagitis. [PDF]

Clin Transl Gastroenterol
Zhu S, Han M, Zong Y, Meng F, Liu Q, Tuo B, Zhang Z, Wang Q, Liu X, He S, Zhen Y, Shao D, Wang S, Xu B, Li X, Tang H, Miu Y, Liu C, Hu J, Hu P, Xiu J, Lu M, Wu Y, Zhang S.   +23 more
europepmc   +1 more source

Exploration of the potential therapeutic effects and targets of Coriandrum sativum on non-erosive esophagitis based on bioinformatics and molecular dynamics simulation. [PDF]

Sci Rep
Shen X, Li B, Chen Y, Wang Y, Zhou W, Deng M, Xu Y.   +6 more
europepmc   +1 more source

Economic and treatment burden among newly diagnosed patients with erosive esophagitis in the US: a national retrospective cohort study. [PDF]

Dis Esophagus
Shaheen NJ, Patel DA, Abeynayake I, Bui B, Gopal M, Jacob R, Chastek B, Steiger C, Shah ED.   +8 more
europepmc   +1 more source

The prevalence, severity, and risk factors of erosive esophagitis in a Middle Eastern population. [PDF]

Saudi J Gastroenterol
Alsahafi M, Salah F, Mimish H, Hejazi M, Alkhiari R, Alkhowaiter S, Mosli M.   +6 more
europepmc   +1 more source

Transcriptomic Insights into Hub Genes, Immune Infiltration, and Candidate Drugs in Erosive Esophagitis. [PDF]

J Inflamm Res
Zhao Y, Chen X, Huang Y, Zhang Z, Wang K, Zou D, Ma T.   +6 more
europepmc   +1 more source

Randomized Multicenter Study to Evaluate the Efficacy and Safety of Fexuprazan According to the Timing of Dosing in Patients With Erosive Esophagitis. [PDF]

J Neurogastroenterol Motil
Lee SP, Sung IK, Lee OY, Choi MG, Huh KC, Jang JY, Chun HJ, Kwon JG, Kim GH, Kim N, Rhee PL, Kim SG, Jung HY, Lee JS, Lee YC, Jung HK, Kim JG, Kim SK, Sohn CI.   +18 more
europepmc   +1 more source